CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $44,466
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$44,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-12 | APPELROUTH STEWART Director | Grant or award · Options to buy Common Stock | +100,000 | 100,000 | ||
| 2018-04-12 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Grant or award · Options to buy Common Stock | +125,000 | 125,000 | ||
| 2018-04-12 | RODINO III PETER W. Dir Govt Relations/Sectry | Grant or award · Options to buy Common Stock | +100,000 | 100,000 | ||
| 2018-04-12 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Options to buy Common Stock | +75,000 | 75,000 | ||
| 2018-04-12 | PASCALE ADAM CFO | Grant or award · Options to buy Common Stock | +75,000 | 75,000 | ||
| 2018-04-12 | SPRINGATE WAYNE S Sr. VP of Operations | Grant or award · Options to buy Common Stock | +75,000 | 75,000 | ||
| 2018-02-13 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +226,023 | 226,023 | ||
| 2018-02-13 | Rodino Peter W. III Dir Govt Relations/Sectry | Grant or award · Options to buy Common Stock | +173,423 | 173,423 | ||
| 2018-02-13 | Springate Wayne S. Sr. VP of Operations | Grant or award · Options to buy Common Stock | +111,486 | 111,486 | ||
| 2018-02-13 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +123,874 | 123,874 | ||
| 2018-02-13 | Equels Thomas K. Exec. Vice Chairman/CEO/Pres. | Grant or award · Options to buy Common Stock | +371,622 | 371,622 | ||
| 2018-02-13 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +226,023 | 226,023 | ||
| 2017-08-31 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +24,463 | $0.26 | $6K | 24,463 |
| 2017-08-31 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +29,757 | $0.26 | $8K | 29,757 |
| 2017-08-31 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +29,757 | $0.26 | $8K | 29,757 |
| 2017-08-31 | Rodino Peter W. III Dir Govt Relations/Sectry | Grant or award · Options to buy Common Stock | +11,416 | $0.26 | $3K | 11,416 |
| 2017-08-31 | Springate Wayne S. Sr. VP of Operations | Grant or award · Options to buy Common Stock | +7,339 | $0.26 | $2K | 7,339 |
| 2017-08-31 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +8,155 | $0.26 | $2K | 8,155 |
| 2017-08-15 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +25,953 | $0.29 | $8K | 25,953 |
| 2017-08-15 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +25,953 | $0.29 | $8K | 25,953 |
Page 16 of 19 · 376 trades